300149 睿智医药
午间休市 10-13 11:30:00
资讯
新帖
简况
睿智医药（300149）10月8日主力资金净卖出1643.37万元
证券之星 · 10-09
睿智医药（300149）10月8日主力资金净卖出1643.37万元
睿智医药（300149）9月30日主力资金净卖出210.01万元
证券之星 · 10-08
睿智医药（300149）9月30日主力资金净卖出210.01万元
睿智医药(300149)9月20日股东户数4.06万户，较上期增加2.65%
证券之星 · 09-28
睿智医药(300149)9月20日股东户数4.06万户，较上期增加2.65%
睿智医药：搭建AI辅助分子设计平台——XDrug.AI
证券之星 · 09-23
睿智医药：搭建AI辅助分子设计平台——XDrug.AI
睿智医药：公司将围绕全链条服务目标，积极补齐产业链薄弱环节
证券之星 · 09-22
睿智医药：公司将围绕全链条服务目标，积极补齐产业链薄弱环节
睿智医药(300149)9月10日股东户数3.96万户，较上期减少1.07%
证券之星 · 09-21
睿智医药(300149)9月10日股东户数3.96万户，较上期减少1.07%
9月21日睿智医药涨7.46%，银河康乐股票A基金重仓该股
证券之星 · 09-21
9月21日睿智医药涨7.46%，银河康乐股票A基金重仓该股
睿智医药：截至2026年9月10日，股东人数为39,557人
证券之星 · 09-21
睿智医药：截至2026年9月10日，股东人数为39,557人
睿智医药最新公告：与香港理工大学及马来西亚国立大学战略合作框架协议到期终止
证券之星 · 09-16
睿智医药最新公告：与香港理工大学及马来西亚国立大学战略合作框架协议到期终止
睿智医药（300149）披露关于独立董事任期满六年辞职的公告，9月10日股价下跌3.24%
证券之星 · 09-10
睿智医药（300149）披露关于独立董事任期满六年辞职的公告，9月10日股价下跌3.24%
睿智医药(300149)8月31日股东户数4万户，较上期减少11.93%
证券之星 · 09-07
睿智医药(300149)8月31日股东户数4万户，较上期减少11.93%
睿智医药（300149）披露2026年半年度报告，8月31日股价下跌4.86%
证券之星 · 08-31
睿智医药（300149）披露2026年半年度报告，8月31日股价下跌4.86%
睿智医药（300149）2026年中报简析：增收不增利，应收账款上升
证券之星 · 08-30
睿智医药（300149）2026年中报简析：增收不增利，应收账款上升
睿智医药(300149)8月10日股东户数4.54万户，较上期增加3.59%
证券之星 · 08-29
睿智医药(300149)8月10日股东户数4.54万户，较上期增加3.59%
图解睿智医药中报：第二季度单季净利润同比下降168.50%
证券之星 · 08-29
图解睿智医药中报：第二季度单季净利润同比下降168.50%
8月24日睿智医药跌6.55%，银河康乐股票A基金重仓该股
证券之星 · 08-24
8月24日睿智医药跌6.55%，银河康乐股票A基金重仓该股
8月21日睿智医药跌8.55%，银河康乐股票A基金重仓该股
证券之星 · 08-21
8月21日睿智医药跌8.55%，银河康乐股票A基金重仓该股
8月20日睿智医药涨10.41%，银河康乐股票A基金重仓该股
证券之星 · 08-20
8月20日睿智医药涨10.41%，银河康乐股票A基金重仓该股
睿智医药(300149)8月10日股东户数4.54万户，较上期增加3.59%
证券之星 · 08-18
睿智医药(300149)8月10日股东户数4.54万户，较上期增加3.59%
睿智医药：截止到2026年8月10日，公司的股东人数为45,400
证券之星 · 08-18
睿智医药：截止到2026年8月10日，公司的股东人数为45,400
加载更多
公司概况
公司名称：
睿智医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2010-12-22
主营业务：
睿智医药科技股份有限公司的主营业务是提供生物药、化学药一站式医药研发及生产服务。公司的主要产品是化学业务、药效药动业务、大分子业务。
发行价格：
28.00
{"stockData":{"symbol":"300149","market":"SZ","secType":"STK","nameCN":"睿智医药","latestPrice":8.74,"timestamp":1791867018000,"preClose":9.1,"halted":0,"volume":14901026,"delay":0,"changeRate":-0.0396,"floatShares":482000000,"shares":505000000,"eps":-0.0851,"marketStatus":"午间休市","change":-0.36,"latestTime":"10-13 11:30:00","open":8.96,"high":9.02,"low":8.51,"amount":130000000,"amplitude":0.056,"askPrice":8.76,"askSize":83,"bidPrice":8.74,"bidSize":11,"shortable":0,"etf":0,"ttmEps":-0.0851,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791867600000},"marketStatusCode":3,"adr":0,"adjPreClose":9.1,"symbolType":"stock","openAndCloseTimeList":[[1791855000000,1791862200000],[1791867600000,1791874800000]],"highLimit":10.01,"lowLimit":8.19,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":504985807,"isCdr":false,"pbRate":3.6,"roa":"--","roe":"--","epsLYR":0.03,"committee":-0.791328,"marketValue":4414000000,"turnoverRate":0.0309,"status":1,"floatMarketCap":4209000000},"requestUrl":"/m/hq/s/300149","defaultTab":"news","newsList":[{"id":"2674888108","title":"睿智医药（300149）10月8日主力资金净卖出1643.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674888108","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674888108?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:19","pubTimestamp":1791508744,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，睿智医药报收于9.45元，下跌4.55%，换手率5.32%，成交量25.62万手，成交额2.46亿元。10月8日的资金流向数据方面，主力资金净流出1643.37万元，占总成交额6.68%，游资资金净流入254.44万元，占总成交额1.03%，散户资金净流入1388.93万元，占总成交额5.65%。融券方面，融券卖出0.0股，融券偿还0.0股，融券余量4.0万股，融券余额37.8万元。睿智医药主营业务：医药研发及生产服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900007342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300149","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673604977","title":"睿智医药（300149）9月30日主力资金净卖出210.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673604977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673604977?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:08","pubTimestamp":1791421691,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，睿智医药报收于9.9元，上涨2.7%，换手率7.0%，成交量33.69万手，成交额3.35亿元。9月30日的资金流向数据方面，主力资金净流出210.01万元，占总成交额0.63%，游资资金净流出473.36万元，占总成交额1.41%，散户资金净流入683.37万元，占总成交额2.04%。融券方面，融券卖出0.0股，融券偿还0.0股，融券余量4.0万股，融券余额39.6万元。睿智医药主营业务：医药研发及生产服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800003017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300149","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670356622","title":"睿智医药(300149)9月20日股东户数4.06万户，较上期增加2.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670356622","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670356622?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:51","pubTimestamp":1790589072,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年9月20日公司股东户数为4.06万户，较9月10日增加1049.0户，增幅为2.65%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至9月20日，医疗服务行业平均股东户数为4.72万户。从股价来看，2026年9月10日至2026年9月20日，睿智医药区间涨幅为3.12%，在此期间股东户数增加1049.0户，增幅为2.65%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800023400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669486395","title":"睿智医药：搭建AI辅助分子设计平台——XDrug.AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486395","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669486395?lang=zh_cn&edition=full","pubTime":"2026-09-23 20:48","pubTimestamp":1790167711,"startTime":"0","endTime":"0","summary":"在生物大分子领域搭建AI辅助抗体发现、多肽虚拟筛选平台；在小分子领域搭建成药性预测平台，对候选分子进行ADMET性质预测及优化筛选，并将人工智能辅助药物设计能力延伸至客户服务，通过大数据分析与机器学习建模，为客户提供分子优化与成药性预测服务；此外，公司搭建了AI 辅助分子设计平台——XDrug.AI，推动药物设计能力由方法工具向可交付的研发服务实现工程化转化。除此之外，公司联合外部AI专家团队合作，共建AI知识库与靶点发现平台。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300038313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669112867","title":"睿智医药：公司将围绕全链条服务目标，积极补齐产业链薄弱环节","url":"https://stock-news.laohu8.com/highlight/detail?id=2669112867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669112867?lang=zh_cn&edition=full","pubTime":"2026-09-22 15:54","pubTimestamp":1790063652,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：公司一直说增发项目完成以后就会启动资产并购。可增发一直不完成。请问公司增发完成以后 还会资产并购吗？主要是哪些方向的资产?睿智医药回复：尊敬的投资者，您好！感谢对公司的关注，公司将结合资本市场环境与公司实际情况，积极稳妥推进本次定增发行工作，并严格按照监管要求及时履行信息披露义务。此外，公司将围绕全链条服务目标，积极补齐产业链薄弱环节。请关注公司的相关公告。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200023949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669542801","title":"睿智医药(300149)9月10日股东户数3.96万户，较上期减少1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669542801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669542801?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:41","pubTimestamp":1789983707,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年9月10日公司股东户数为3.96万户，较8月31日减少429.0户，减幅为1.07%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至9月10日，医疗服务行业平均股东户数为4.73万户。从股价来看，2026年8月31日至2026年9月10日，睿智医药区间跌幅为2.61%，在此期间股东户数减少429.0户，减幅为1.07%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100022715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300149","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159262","title":"9月21日睿智医药涨7.46%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159262?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:46","pubTimestamp":1789980365,"startTime":"0","endTime":"0","summary":"证券之星消息，9月21日睿智医药涨7.46%，收盘报9.94元，换手率10.18%，成交量49.02万手，成交额4.77亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100021009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669153388","title":"睿智医药：截至2026年9月10日，股东人数为39,557人","url":"https://stock-news.laohu8.com/highlight/detail?id=2669153388","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669153388?lang=zh_cn&edition=full","pubTime":"2026-09-21 15:07","pubTimestamp":1789974440,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)09月21日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问一下9月10号的股东人数是多少？谢谢睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。截至2026年9月10日，股东人数为39,557人。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100013463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667604530","title":"睿智医药最新公告：与香港理工大学及马来西亚国立大学战略合作框架协议到期终止","url":"https://stock-news.laohu8.com/highlight/detail?id=2667604530","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667604530?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:45","pubTimestamp":1789551920,"startTime":"0","endTime":"0","summary":"睿智医药(300149.SZ)公告称，公司全资子公司上海睿智与香港理工大学签署的战略合作框架协议合作期限已届满，双方未达成续期安排，协议自动终止；公司与马来西亚国立大学、PHARMAMEDICALSDNBHD.签署的战略合作框架协议因合作期限届满亦自动终止。上述协议终止不会影响公司业务独立性及正常生产经营，各方互不承担违约责任。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600028353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666561124","title":"睿智医药（300149）披露关于独立董事任期满六年辞职的公告，9月10日股价下跌3.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666561124","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666561124?lang=zh_cn&edition=full","pubTime":"2026-09-10 17:32","pubTimestamp":1789032728,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，睿智医药报收于8.97元，较前一交易日下跌3.24%，最新总市值为45.3亿元。睿智医药科技股份有限公司董事会于近日收到独立董事郭志成先生的书面辞职报告。郭志成先生自2020年9月10日起担任公司独立董事，连续任职即将届满六年，根据《上市公司独立董事管理办法》规定，申请辞去公司第六届董事会独立董事、审计委员会主任委员和薪酬与考核委员会委员职务。公司董事会对郭志成先生在任职期间的贡献表示感谢。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000031588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665314374","title":"睿智医药(300149)8月31日股东户数4万户，较上期减少11.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665314374","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665314374?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:49","pubTimestamp":1788774555,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年8月31日公司股东户数为4.0万户，较8月10日减少5414.0户，减幅为11.93%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至8月31日，医疗服务行业平均股东户数为4.76万户。从股价来看，2026年8月10日至2026年8月31日，睿智医药区间跌幅为12.12%，在此期间股东户数减少5414.0户，减幅为11.93%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700023292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079783","title":"睿智医药（300149）披露2026年半年度报告，8月31日股价下跌4.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079783","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663079783?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:43","pubTimestamp":1788169383,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，睿智医药报收于9.21元，较前一交易日下跌4.86%，最新总市值为46.51亿元。该股当日开盘9.3元，最高9.47元，最低9.1元，成交额达2.83亿元，换手率为6.34%。近日，睿智医药科技股份有限公司披露《2026年半年度报告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100024531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663272048","title":"睿智医药（300149）2026年中报简析：增收不增利，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663272048","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663272048?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:27","pubTimestamp":1788042472,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期睿智医药发布2026年中报。本报告期睿智医药应收账款上升，应收账款同比增幅达36.09%。去年的净利率为1.19%，算上全部成本后，公司产品或服务的附加值不高。本文数据来源于睿智医药2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000002958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012964","title":"睿智医药(300149)8月10日股东户数4.54万户，较上期增加3.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012964","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012964?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:16","pubTimestamp":1787995008,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年8月10日公司股东户数为4.54万户，较7月31日增加1572.0户，增幅为3.59%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至8月10日，医疗服务行业平均股东户数为4.75万户。从股价来看，2026年7月31日至2026年8月10日，睿智医药区间涨幅为17.09%，在此期间股东户数增加1572.0户，增幅为3.59%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013332","title":"图解睿智医药中报：第二季度单季净利润同比下降168.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013332","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663013332?lang=zh_cn&edition=full","pubTime":"2026-08-29 03:24","pubTimestamp":1787945090,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药2026年中报显示，上半年度公司主营收入5.62亿元，同比上升5.37%；归母净利润-3099.33万元，同比下降222.11%；扣非净利润-3194.82万元，同比下降570.36%；其中2026年第二季度，公司单季度主营收入2.96亿元，同比上升8.53%；单季度归母净利润-1283.68万元，同比下降168.5%；单季度扣非净利润-1219.8万元，同比下降245.85%；负债率34.32%，投资收益-176.56万元，财务费用1673.51万元，毛利率23.66%。财报数据概要请见下图:本文数据来源于睿智医药2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900007386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661210172","title":"8月24日睿智医药跌6.55%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661210172","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661210172?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:39","pubTimestamp":1787560787,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日睿智医药跌6.55%，收盘报9.7元，换手率7.03%，成交量33.86万手，成交额3.36亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400022092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661244265","title":"8月21日睿智医药跌8.55%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661244265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661244265?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:45","pubTimestamp":1787301939,"startTime":"0","endTime":"0","summary":"证券之星消息，8月21日睿智医药跌8.55%，收盘报10.38元，换手率10.95%，成交量52.73万手，成交额5.58亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100029646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402067","title":"8月20日睿智医药涨10.41%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402067","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660402067?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:42","pubTimestamp":1787215326,"startTime":"0","endTime":"0","summary":"证券之星消息，8月20日睿智医药涨10.41%，收盘报11.35元，换手率16.2%，成交量78.04万手，成交额8.73亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000028982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660465255","title":"睿智医药(300149)8月10日股东户数4.54万户，较上期增加3.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660465255","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660465255?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:29","pubTimestamp":1787045392,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年8月10日公司股东户数为4.54万户，较7月31日增加1572.0户，增幅为3.59%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至8月10日，医疗服务行业平均股东户数为4.83万户。从股价来看，2026年7月31日至2026年8月10日，睿智医药区间涨幅为17.09%，在此期间股东户数增加1572.0户，增幅为3.59%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800030654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453626","title":"睿智医药：截止到2026年8月10日，公司的股东人数为45,400","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660453626?lang=zh_cn&edition=full","pubTime":"2026-08-18 08:51","pubTimestamp":1787014274,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)08月17日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至8月10日公司股东人数是多少？睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。截止到2026年8月10日，公司的股东人数为45,400。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800007573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0216","BK0077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791867022862,"stockEarnings":[{"period":"1week","weight":-0.0808},{"period":"1month","weight":0.0412},{"period":"3month","weight":0.0508},{"period":"6month","weight":-0.2148},{"period":"1year","weight":-0.2094},{"period":"ytd","weight":-0.0481}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":-0.0234},{"period":"3month","weight":-0.0428},{"period":"6month","weight":-0.0571},{"period":"1year","weight":-0.0256},{"period":"ytd","weight":-0.0432}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"睿智医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"40606人(较上一季度增加2.65%)","perCapita":"11859股","listingDate":"2010-12-22","address":"广东省江门市江海区胜利南路164号","registeredCapital":"50498万元","survey":" 睿智医药科技股份有限公司的主营业务是提供生物药、化学药一站式医药研发及生产服务。公司的主要产品是化学业务、药效药动业务、大分子业务。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供睿智医药(300149)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"睿智医药,300149,睿智医药股票,睿智医药股票老虎,睿智医药股票老虎国际,睿智医药行情,睿智医药股票行情,睿智医药股价,睿智医药股市,睿智医药股票价格,睿智医药股票交易,睿智医药股票购买,睿智医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供睿智医药(300149)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}